Oxidative stress, gene expression, and protein changes induced in the human placenta during labor

American Journal of Pathology

Volumn 171, Issue 4, 2007, Pages 1168-1179

  Cindrova Davies, Tereza ^a   Yung, Hong Wa ^a   Johns, Jemma ^b   Spasic Boskovic, Olivera ^a   Korolchuk, Svitlana ^a   Jauniaux, Eric ^b   Burton, Graham J ^a   Charnock Jones, D Stephen ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LABOR; MICROARRAY ANALYSIS; OXIDATIVE STRESS; PLACENTA; PLACENTA DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL;

EID: 35348903110     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.070528     Document Type: Article

References (59)

1. Hubel CA: Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med 1999, 222:222-235
2. Myatt L, Cui X: Oxidative stress in the placenta. Histochem Cell Biol 2004, 122:369-382
3. Burton GJ, Jauniaux E: Placental oxidative stress: from miscarriage to preeclampsia. J Soc Gynecol Invest 2004, 11:342-352
4. Brosens IA: Morphological changes in the utero-placental bed in pregnancy hypertension. Clin Obstet Gynaecol 1977, 4:573-593
5. Kim YM, Bujold E, Chaiworapongsa T, Gomez R, Yoon BH, Thaler HT, Rotmensch S, Romero R: Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2003, 189:1063-1069
6. Kim YM, Chaiworapongsa T, Gomez R, Bujold E, Yoon BH, Rotmensch S, Thaler HT, Romero R: Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes. Am J Obstet Gynecol 2002, 187:1137-1142
7. Brosens IA, Robertson WB, Dixon HG: The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet Gynecol Annu 1972, 1:177-191
8. Hung T-H, Skepper JN, Burton GJ: In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol 2001, 159:1031-1043
9. Cindrova-Davies T, Spasic-Boskovic O, Jauniaux E, Charnock-Jones DS, Burton GJ: NF-κB, p38 and stress activated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress. Am J Pathol 2007, 170:1511-1520
10. Hung T-H, Skepper JN, Charnock-Jones DS, Burton GJ: Hypoxiareoxygenation: a potent inducer of apoptotic changes in the human placenta and possible etiological factor in preeclampsia. Circ Res 2002, 90:1274-1281
11. Hung T-H, Charnock-Jones DS, Skepper JN, Burton GJ: Secretion of tumor necrosis factor-α from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potent mediator of the inflammatory response in preeclampsia. Am J Pathol 2004, 164:1049-1061
12. Tjoa M-L, Cindrova-Davies T, Spasic-Boskovic O, Bianchi DW, Burton GJ: Trophoblastic oxidative stress and the release of cell-free fetoplacental DNA. Am J Pathol 2006, 169:400-404
13. Bainbridge SA, Belkacemi L, Dickinson M, Graham CH, Smith GN: Carbon monoxide inhibits hypoxia/reoxygenation-induced apoptpsis and secondary necrosis in syncytiotrophoblast. Am J Pathol 2006, 169:774-783
14. Brar HS, Platt LD, DeVore GR, Horenstein J, Medearis AL: Qualitative assessment of maternal uterine and fetal umbilical artery blood flow and resistance in laboring patients by Doppler velocimetry. Am J Obstet Gynecol 1988, 158:952-956
15. Fleischer A, Anyaegbunam AA, Schulman H, Farmakides G, Randolph G: Uterine and umbilical artery velocimetry during normal labor. Am J Obstet Gynecol 1987, 157:40-43
16. Ramsey E, Donner M: Placental vasculature and circulation. Anatomy, Physiology, Radiology, Clinical Aspects Atlas and Textbook. Stuttgart, Georg Thieme Publishers Stuttgart, 1980
17. Many A, Roberts JM: Increased xanthine oxidase during labour - implications for oxidative stress. Placenta 1997, 18:725-726
18. Bloxam DL, Bobinski PM: Energy metabolism and glycolysis in the human placenta during ischaemia and in normal labour. Placenta 1984, 5:381-394
19. Woods JR, Cavanaugh JL, Normkus EP, Plessinger MA, Miller RK: The effect of labor on maternal and fetal vitamins C and E. Am J Obstet Gynecol 2002, 187:1179-1183
20. Raijmakers MT, Roes EM, Steegers EA, van der Wildt B, Peters WH: Umbilical glutathione levels are higher after vaginal birth than after cesarean section. J Perinatal Med 2003, 31:520-522
21. Kniss DA: Cyclooxygenases in reproductive medicine and biology. J Soc Gynecol Invest 1999, 6:285-292
22. Philpott RH, Castle WM: Cervicographs in the management of labour in primigravidae. I. The alert line for detecting abnormal labour. J Obstet Gynaecol Br Commonw 1972, 79:592-598
23. Philpott RH, Castle WM: Cervicographs in the management of labour in primigravidae. II. The action line and treatment of abnormal labour. J Obstet Gynaecol Br Commonw 1972, 79:599-602
24. Hung SP, Baldi P, Hatfield GW: Global gene expression profiling in Escherichia coli K12: effects of leucine-responsive regulatory protein. J Biol Chem 2002, 277:40309-40323
25. Baldi P, Long AD: A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics 2001, 17:509-519
26. Al-Shahrour F, Diaz-Uriarte R, Dopazo J: FatiGO: a web tool for finding significant associations of Gene Ontology terms with groups of genes. Bioinformatics 2004, 20:578-580
27. Rajakumar A, Conrad KP: Expression, ontogeny, and regulation of hypoxia-inducible transcription factors in the human placenta. Biol Reprod 2000, 63:559-569
28. McCord JM: Human disease, free radicals, and the oxidant/antioxidant balance. Clin Biochem 1993, 26:351-357
29. Borell U, Fernstroem I, Ohlson L, Wiqvist N: Influence of uterine contractions on the uteroplacental blood flow at term. Am J Obstet Gynecol 1965, 93:44-57
30. Romero R, Mazor M, Brandt F, Sepulveda W, Avila C, Cotton DB, Dinarello CA: Interleukin-1 alpha and interleukin-1 beta in preterm and term human parturition. Am J Reprod Immunol 1992, 27:117-123
31. Opsjłn SL, Wathen NC, Tingulstad S, Wiedswang G, Sundan A, Waage A, Austgulen R: Tumor necrosis factor, interleukin-1, and interleukin-6 in normal human pregnancy. Am J Obstet Gynecol 1993, 169:397-404
32. Allport VC, Pieber D, Slater DM, Newton R, White JO, Bennett PR: Human labour is associated with nuclear factor-κB activity which mediates cyclo-oxygenase-2 expression and is involved with the 'functional progesterone withdrawal'. Mol Hum Reprod 2001, 7:581-586
33. Burdon C, Mann C, Cindrova-Davies T, Ferguson-Smith AC, Burton GJ: Oxidative stress and the induction of cyclooxygenase enzymes and apoptosis in the murine placenta. Placenta 2007, 28:724-733
34. Highman TJ, Friedman JE, Huston LP, Wong WW, Catalano PM: Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy, Am J Obstet Gynecol 1998, 178:1010-1015
35. Lage M, Garcia-Mayor RV, Tome MA, Cordido F, Valle-Inclan F, Considine RV, Caro JF, Dieguez C, Casanueva FF: Serum leptin levels in women throughout pregnancy and the ppstpartum period and in women suffering spontaneous abortion. Clin Endocrinol (Oxf) 1999, 50:211-216
36. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, Nishimura H, Yoshimasa Y, Tanaka I, Mori T, Nakao K: Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med 1997, 3:1029-1033
37. Nuamah MA, Yura S, Sagawa N, Itoh H, Mise H, Korita D, Kakui K, Takemura M, Ogawa Y, Nakao K, Fujii S: Significant increase in maternal plasma leptin concentration in induced delivery: a possible contribution of pro-inflammatory cytokines to placental leptin secretion. Endocr J 2004, 51:177-187
38. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003, 111:649-658
39. Redman CW, Sargent IL: Latest advances in understanding preeclampsia. Science 2005, 308:1592-1594
40. Dvorak HF: Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. J Clin Oncol 2002, 20:4368-4380
41. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N: Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 1998, 273:30336-30343
42. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004, 350:672-683
43. Li H, Gu B, Zhang Y, Lewis DF, Wang Y: Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta 2005, 26:210-217
44. Gerber HP, Condorelli F, Park J, Ferrra N: Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem 1997, 272:23659-23667
45. Jung Y-J, Isaacs JS, Lee S, Trepel J, Neckers L: IL-1β mediated up-regulation of HIF-1α via an NFκB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 2003, 17:2115-2117
46. Jung Y-J, Isaacs JS, Lee S, Trepel J, Liu ZG, Neckers L: Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappaB activation. Biochem J 2003, 370:1011-1017
47. Jung Y-J, Isaacs JS, Lee S, Trepel J, Neckers L: Microtubule disruption utilizes an NFkappa B-dependent pathway to stabilize HIF-1alpha protein. J Biol Chem 2003, 278:7445-7452
48. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA: Placental apoptosis in preeclampsia. Obstet Gynecol 2000, 96:271-276
49. Leung DN, Smith SC, To KF, Sahota DS, Baker PN: Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2001, 184:1249-1250
50. Redman CWG, Sargent IL: Placental debris, oxidative stress and pre-eclampsia. Placenta 2000, 21:597-602
51. Li RH, Poon SC, Yu MY, Wong YF: Expression of placental leptin and leptin receptors in preeclampsia. Int J Gynecol Pathol 2004, 23:378-385
52. Helske S, Vuorela P, Carpen O, Hornig C, Weich H, Halmesmaki E: Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod 2001, 7:205-210
53. Koh SC, Anandakumar C, Montan S, Ratnam SS: Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in pre-eclampsia. Gynecol Obstet Invest 1993, 35:214-221
54. Deng L, Bremme K, Hansson LO, Blomback M: Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia. Obstet Gynecol 1994, 84:941-945
55. Torry DS, Wang HS, Wang TH, Caudle MR, Torry RJ: Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 1998, 179:1539-1544
56. Reith A, Booth NA, Moore NR, Cruickshank DJ, Bennett B: Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, pre-eclampsia and hydatidiform mole. Br J Obstet Gynaecol 1993, 100:370-374
57. Carrasco G, Cruz MA, Dominguez A, Gallardo V, Miguel P, Gonzalez C: The expression and activity of monoamine oxidase A, but not of the serotonin transporter, is decreased in human placenta from pre-eclamptic pregnancies. Life Sci 2000, 67:2961-2969
58. Jauniaux E, Watson AL, Hempstock J, Bao Y-P, Skepper JN, Burton GJ: Onset of maternal arterial blood flow placental oxidative stress; a possible factor in human early pregnancy failure. Am J Pathol 2000, 157:2111-2122
59. Chames MC, Livingston JC, Ivester TS, Barton JR, Sibai BM: Late postpartum eclampsia: a preventable disease? Am J Obstet Gynecol 2002, 186:1174-1177